This page was added on 04 June 2018.
This page was updated on [date-counter-updated-date]. View history of updates
Registered for use in infants and children aged 2 months to 5 years.
Monovalent Haemophilus influenzae type b (Hib) vaccine.
Lyophilised pellet in a monodose vial with separate diluent.
Each 0.5 mL reconstituted dose contains:
- 10 µg Hib capsular polysaccharide (polyribosyl-ribitol-phosphate) conjugated to approximately 25 µg tetanus toxoid (PRP-T)
For Product Information and Consumer Medicine Information about Hiberix visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.